Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation-Reference-Cited by-同舟云学术

Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation

Published:2014-02-24 Issue:2 Volume:9 Page:e89735
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Martins Karen A. O.,Steffens Jesse T.,van Tongeren Sean A.,Wells Jay B.,Bergeron Alison A.,Dickson Samuel P.,Dye John M.,Salazar Andres M.,Bavari Sina

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference59 articles.

1. Progress in filovirus vaccine development: evaluating the potential for clinical use;D Falzarano;Expert Rev Vaccines,2011

2. Ebolavirus vaccines for humans and apes;H Fausther-Bovendo;Curr Opin Virol,2012

3. Viral vectors as vaccine platforms: deployment in sight;CS Rollier;Curr Opin Immunol,2011

4. Role of natural killer cells in innate protection against lethal ebola virus infection;KL Warfield;J Exp Med,2004

5. Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection;KL Warfield;J Immunol,2005

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine adjuvants and carriers;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

2. Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge;npj Vaccines;2023-02-08

3. Double-stranded RNAs are promising adjuvants for enhancing immunogenicity of vaccines;Journal of microbiology, epidemiology and immunobiology;2023-01-10

4. Promising Marine Natural Products for Tackling Viral Outbreaks: A Focus on Possible Targets and Structure-Activity Relationship;Current Topics in Medicinal Chemistry;2022-08-31

5. Design and Functional Characterization of HIV-1 Envelope Protein-Coupled T Helper Liposomes;Pharmaceutics;2022-06-30